The risk of multiple primary breast and thyroid carcinomas
- PMID: 12973856
- DOI: 10.1002/cncr.11626
The risk of multiple primary breast and thyroid carcinomas
Abstract
Background: Some studies have suggested that there is an association between breast carcinoma and thyroid carcinoma. Because ionizing radiation is a well known risk factor for breast and thyroid carcinomas, the authors studied the effect of the radiation dose delivered for the treatment of each of these two malignancies on the risk of subsequently developing the other malignancy.
Methods: The risk of developing thyroid carcinoma subsequent to treatment for breast carcinoma was analyzed in 8 patients (cases) and 192 matched control patients (controls) nested in a cohort of 7711 women who were treated at Institut Gustave Roussy between 1954 and 1983. The risk of developing breast carcinoma after treatment for thyroid carcinoma was studied in a cohort of 2365 women who were treated in 3 French cancer centers between 1934 and 1995.
Results: Six of 8 patients with breast carcinoma (75%) who developed thyroid carcinoma and 71% of patients in the control group received radiation therapy during their treatment. The median dose to the thyroid was 6.6 grays (Gy) in the case group and 9.4 Gy in the control group. The overall relative risk of thyroid carcinoma associated with radiation therapy was 1.2 (95% confidence interval, 0.2-6.2). No relation was observed between the radiation dose and the risk of thyroid carcinoma (P = 0.8). Among 2365 women who were treated for thyroid carcinoma, 48 women developed a subsequent breast carcinoma. A significant excess of breast carcinoma was observed among women younger than 59 years at the time of diagnosis of breast carcinoma compared with women in the same age group in the general population. The mean absorbed dose delivered to the breasts by (131)I and external radiation therapy was 0.7 Gy. No relation was found between the radiation dose and the risk of breast carcinoma (P = 0.8).
Conclusions: The previously reported excess incidence of breast carcinoma after thyroid carcinoma was not related to radiation treatment with (131)I and/or external radiation therapy. Radiation therapy for breast carcinoma did not increase the risk of subsequent thyroid carcinoma.
Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11626
Similar articles
-
Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy.Radiother Oncol. 2009 Nov;93(2):377-82. doi: 10.1016/j.radonc.2009.05.011. Epub 2009 Jun 8. Radiother Oncol. 2009. PMID: 19515442
-
Increased breast cancer risk after radiotherapy for acne among women with skin cancer.J Am Acad Dermatol. 2006 Dec;55(6):981-9. doi: 10.1016/j.jaad.2005.10.005. Epub 2006 Aug 14. J Am Acad Dermatol. 2006. PMID: 17097395
-
Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.Breast Cancer Res Treat. 2005 Feb;89(3):277-88. doi: 10.1007/s10549-004-2472-8. Breast Cancer Res Treat. 2005. PMID: 15754127
-
Estimation of cancer risks from radiotherapy of benign diseases.Strahlenther Onkol. 2006 Aug;182(8):431-6. doi: 10.1007/s00066-006-1542-8. Strahlenther Onkol. 2006. PMID: 16896588 Review.
-
Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.Radiother Oncol. 2009 Apr;91(1):4-15; discussion 1-3. doi: 10.1016/j.radonc.2008.12.016. Epub 2009 Feb 5. Radiother Oncol. 2009. PMID: 19201045 Review.
Cited by
-
Thyroid cancer in Luxembourg: a national population-based data report (1983-1999).BMC Cancer. 2006 Apr 24;6:102. doi: 10.1186/1471-2407-6-102. BMC Cancer. 2006. PMID: 16635261 Free PMC article.
-
The prognosis and treatment of primary thyroid cancer occurred in breast cancer patients: comparison with ordinary thyroid cancer.Ann Surg Treat Res. 2014 Apr;86(4):169-76. doi: 10.4174/astr.2014.86.4.169. Epub 2014 Mar 25. Ann Surg Treat Res. 2014. PMID: 24783175 Free PMC article.
-
Thyroid disease is associated with an increased risk of breast cancer: a systematic review and meta-analysis.Gland Surg. 2021 Jan;10(1):336-346. doi: 10.21037/gs-20-878. Gland Surg. 2021. PMID: 33633990 Free PMC article.
-
Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer.World J Surg Oncol. 2011 Aug 12;9:88. doi: 10.1186/1477-7819-9-88. World J Surg Oncol. 2011. PMID: 21835042 Free PMC article.
-
Association of Radioiodine for Differentiated Thyroid Cancer and Second Breast Cancer in Female Adolescent and Young Adult.Front Endocrinol (Lausanne). 2022 Jan 28;12:805194. doi: 10.3389/fendo.2021.805194. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35154006 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical